As per report from Straits Times – A team at the University of Pittsburgh School of Medicine in the United States said they were able to move quickly in developing a potential Covid-19 vaccine after working on other coronaviruses that cause Severe Acute Respiratory Syndrome (Sars) and Middle East Respiratory Syndrome (Mers).
The initial tests of this vaccine in mice of a potential Covid-19 vaccine delivered via a fingertip-sized patch have shown it can induce an immune response against the new coronavirus at levels that might prevent infection, US scientists said on Thursday (April 2).
When tested in mice, the prototype vaccine – which the researchers have called PittCoVacc – generated what they described as “a surge of antibodies” against the new coronavirus within two weeks which is a music to our ear. But again, this vaccine is not 100% as the animals have not been tracked for very long as yet, it is too early to say whether and for how long the immune response against Covid-19 lasts.
But they said that in comparable tests in mice with their Mers experimental vaccine, a sufficient level of antibodies was produced to neutralise the virus for at least a year.
Let’s hope that this vaccine really works and we can go back to our normal life.